<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28159853</article-id><article-id pub-id-type="pmc">5294002</article-id><article-id pub-id-type="publisher-id">bmjopen-2016-013571</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2016-013571</article-id><article-categories><subj-group subj-group-type="heading"><subject>Ophthalmology</subject><subj-group><subject>Research</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1718</subject><subject>1724</subject></subj-group></article-categories><title-group><article-title>Vascular flow density in pathological myopia: an optical coherence tomography angiography study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mo</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Anli</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Szyyann</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xuefei</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Wenbin</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Beijing Ophthalmology and Visual Science Key Lab</addr-line>, <institution>Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff><aff id="af2"><label>2</label><addr-line>Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing</addr-line>, <country>China</country></aff><author-notes><corresp><label>Correspondence to</label> Professor Wenbin Wei; <email>weiwenbintr@163.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>3</day><month>2</month><year>2017</year></pub-date><volume>7</volume><issue>2</issue><elocation-id>e013571</elocation-id><history><date date-type="received"><day>24</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>4</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2016-013571.pdf"/><abstract><sec><title>Objectives</title><p>To investigate vascular flow density in pathological myopia with optical coherence tomography (OCT) angiography.</p></sec><sec><title>Design</title><p>A prospective comparative study was conducted from December 2015 to March 2016.</p></sec><sec><title>Setting</title><p>Participants were recruited in Beijing Tongren Hospital.</p></sec><sec><title>Participants</title><p>A total of 131 eyes were enrolled, which were divided into three groups: 45 eyes with emmetropia (EM; mean spherical equivalent (MSE) 0.50D to &#x02212;0.50D), 41 eyes with high myopia (HM; MSE &#x02264;&#x02212;6.00D, without pathological changes), and 45 eyes with pathological myopia (PM; MSE &#x02264;&#x02212;6.00D and axial length (AL) &#x02265;26.5&#x02005;mm, and with pathological changes).</p></sec><sec><title>Main outcome measures</title><p>Macular, choriocapillaris and radial peripapillary capillary (RPC) flow densities were measured and compared between groups, and their relationships with AL and best corrected visual acuity (BCVA) were analysed.</p></sec><sec><title>Results</title><p>Significant differences were found in macular, choriocapillaris and RPC flow densities among the three groups (p&#x0003c;0.05). Multiple comparisons revealed that, compared with the EM and HM groups, macular and RPC flow densities of the PM group were significantly decreased (p&#x0003c;0.05), but no significant difference in choriocapillaris flow density was found between the PM and HM groups (p=0.731). Compared with the EM group, retinal flow density in the macular and arcuate fibre region was not decreased in the HM group. In addition, there was a negative correlation between AL and superficial macular flow density (&#x003b2;=&#x02212;0.542, p&#x0003c;0.001), deep macular flow density (&#x003b2;=&#x02212;0.282, p=0.002) and RPC flow density (&#x003b2;=&#x02212;0.522, p&#x0003c;0.001); and a positive correlation between BCVA and superficial macular flow density (&#x003b2;=0.194, p=0.021), deep macular flow density (&#x003b2;=0.373, p&#x0003c;0.001), and choriocapillaris flow density (&#x003b2;=0.291, p=0.001).</p></sec><sec><title>Conclusions</title><p>Macular and RPC flow densities decreased in pathological myopia compared with high myopia and emmetropia. No significant decrease of retinal flow density in the macular and arcuate fibre region was found in high myopic eyes compared with emmetropic eyes. Moreover, macular and RPC flow densities were negatively related to AL, and macular flow density was positively related to BCVA.</p></sec></abstract><kwd-group><kwd>Pathologic Myopia</kwd><kwd>OCT Angiography</kwd><kwd>Vascular Flow Density</kwd></kwd-group></article-meta></front><body><boxed-text position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet"><list-item><p>This study investigated the vascular flow density in pathologically myopic eyes with optical coherence tomography angiography.</p></list-item><list-item><p>This study was limited by its cross-sectional design, single-centre and monoracial background.</p></list-item><list-item><p>The mechanisms of the decreased ocular perfusion and how to preserve or improve perfusion in pathological myopic eyes required further study.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Pathological myopia (PM) is one of the major causes of visual impairment and legal blindness worldwide,<xref rid="R1" ref-type="bibr">1</xref>
<xref rid="R2" ref-type="bibr">2</xref> especially in East Asia.<xref rid="R3" ref-type="bibr">3&#x02013;5</xref> The principal alterations in PM include excessive axial elongation of the globe and associated deformation of the posterior ocular segment, with posterior staphyloma as an important primary sign. Secondary to the increased axial length (AL) and staphyloma formation, a range of retinal and choroidal lesions may develop in the posterior pole in eyes with PM.<xref rid="R6" ref-type="bibr">6</xref>
<xref rid="R7" ref-type="bibr">7</xref> Several studies have revealed vascular changes in high myopia (HM) and PM, and such changes may be related to the pathogenesis of PM.<xref rid="R8" ref-type="bibr">8&#x02013;11</xref></p><p>Different techniques have been used to study retinal or choroidal blood flow in myopic eyes. Fluorescein angiography (FA) has been used to observe ocular circulation in myopia, but FA could not image the radial peripapillary or deep capillary networks well.<xref rid="R8" ref-type="bibr">8</xref>
<xref rid="R12" ref-type="bibr">12</xref> Indocyanine green angiography (ICGA) was used to observe retrobulbar vessels and choroidal vasculatures in PM, but ICGA could not visualise the microvasculature well.<xref rid="R13" ref-type="bibr">13</xref> In addition, FA and ICGA were not commonly used in myopia because of their invasive nature and difficulty in quantification. Colour Doppler imaging (CDI) has been used to obtain precise measurements of choroidal and retinal blood flow,<xref rid="R9" ref-type="bibr">9</xref> but it was not sensitive enough to accurately measure the macular and peripapillary microcirculation. Optical coherence tomography (OCT) angiography with split-spectrum amplitude-decorrelation angiography (SSADA) is a recently developed clinical tool, which has allowed for non-invasive and quantitative investigation of retinal and choroidal vasculature, including the microvasculature.<xref rid="R12" ref-type="bibr">12</xref>
<xref rid="R14" ref-type="bibr">14&#x02013;16</xref></p><p>The purpose of this study was to investigate the macular and peripapillary vascular flow density of pathologically myopic eyes with OCT angiography, and to determine whether ocular circulation was altered in the pathologically myopic eye.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Participants</title><p>This observational, cross-sectional study included 45 eyes with PM and 41 eyes with HM, which were enrolled from December 2015 to March 2016 in the department of ophthalmology in Beijing Tongren Hospital. At the same time age-matched and sex-matched 45 healthy control eyes were recruited. Written informed consents were obtained from all study participants.</p><p>The study eyes were divided into three groups: (1) emmetropia (EM; mean spherical equivalent (MSE) 0.50D to &#x02212;0.50D); (2) HM (MSE &#x02264;&#x02212;6.00D, and without pathological changes); (3) PM (MSE &#x02264;&#x02212;6.00D and AL &#x02265;26.5&#x02005;mm, and according to the definition and classification (five categories) stated by the &#x02018;META analysis for Pathologic Myopia (META-PM)&#x02019; study group classification<xref rid="R6" ref-type="bibr">6</xref> PM was defined as eyes having chorioretinal atrophy equal to or more severe than diffuse atrophy).</p><p>Exclusion criteria included: (1) having other ocular diseases such as glaucoma or any retinal vascular disease; (2) a history of systemic diseases such as diabetes mellitus which might affect the ocular circulation; (3) a history of intraocular surgery, laser photocoagulation or ocular injury.</p></sec><sec id="s2b"><title>Examination</title><p>All study participants underwent a complete ophthalmic examination, which included measurement of best corrected visual acuity (BCVA), refractive status assessment using an automatic refractometer (Auto Refractometer RM-8900 Topcon, Tokyo, Japan), calculation of the MSE using the spherical dioptre plus one-half of the cylindrical dioptre, intraocular pressure (IOP) measurement using a non-contact tonometer (Full Auto Tonometer TX-F; Topcon, Tokyo, Japan), slit-lamp assisted biomicroscopy (Haag-Streit, 3098 Koeniz, Switzerland) and fundus photography (Hybrid Digital Mydriatic Retinal Camera CX-1 Canon, Tokyo, Japan), and AL measurement using IOL Master (CarlZeiss, Jena, Germany). Blood pressure was also measured.</p><p>OCT angiography scans were obtained using RTVue XR OCT (Optovue, Fremont, California, USA, Software V.2015.100.0.35.) with the angio retina mode (3&#x000d7;3&#x02005;mm) and the angio disc mode (4.5&#x000d7;4.5&#x02005;mm). The technique of OCT angiography including the SSADA method has been described in detail recently.<xref rid="R14" ref-type="bibr">14&#x02013;16</xref> Vascular flow density was defined as the percentage area occupied by vessels.</p><p>Exclusion criteria for OCT angiography scans included: (1) signal strength index &#x0003c;40; (2) low quality of images with severe artefacts because of poor fixation; (3) PM with epiretinal membrane, foveoschisis, macular holes, choroidal neovascularisation and retinal detachment; these complications might interfere with the automatic layer segmentation software.</p><sec id="s2b1"><title>Retinal density of macular angiogram</title><p>For measurement of retinal density, a 3&#x000d7;3&#x02005;mm macular angiogram of superficial and deep layers was analysed using Optovue software with density function. Each of the layers was automatically segmented by the software: superficial retinal layer extending from the inner limiting membrane with an interface offset of 3&#x02005;&#x000b5;m to the inner plexiform layer (IPL) with an interface offset of 16&#x02005;&#x000b5;m; deep retinal layer extending from the IPL with an interface offset of 16&#x02005;&#x000b5;m to the IPL with an interface offset of 69&#x02005;&#x000b5;m. Flow density was separately calculated in five regions (fovea, tempo, superior, nasal and inferior) based on the ETDRS (Early Treatment Diabetic Retinopathy Study) contour (<xref ref-type="fig" rid="BMJOPEN2016013571F1">figure 1</xref>A). The whole en face flow density and parafovea flow density were also measured.</p><fig id="BMJOPEN2016013571F1" orientation="portrait" position="float"><label>Figure&#x000a0;1</label><caption><p>(A) Macular flow density was separately calculated in five regions (fovea, tempo, superior, nasal, and inferior) based on the ETDRS contour. The whole en face flow density was also measured. (B) RPC flow density was separately calculated in six regions (nasal, inferior-nasal, inferior-tempo, superior-tempo, superior nasal and tempo) based on the Garway-Heath Map. The whole en face and inside disc flow density was also measured. ETDRS, Early Treatment Diabetic Retinopathy Study; RPC, radial peripapillary capillary.</p></caption><graphic xlink:href="bmjopen2016013571f01"/></fig></sec><sec id="s2b2"><title>Choriocapillary density of macular angiogram</title><p>For measurement of choriocapillary density, a 3&#x000d7;3&#x02005;mm macular angiogram of the choriocapillary layer (from RPE with an RPE offset of 31&#x02005;&#x000b5;m to the deeper layer with an RPE offset of 59&#x02005;&#x000b5;m) was analysed using Optovue software with flow function. Choriocapillary density was calculated as vessel areas of choriocapillaris divided by selected areas (9&#x02005;mm<sup>2</sup>).</p></sec><sec id="s2b3"><title>Radial peripapillary capillary flow density of disc angiogram</title><p>For measurement of parameters of the disc angiogram, a 4.5&#x000d7;4.5&#x02005;mm large en face image was analysed with Optovue software with density function. The software automatically defined the contour of the optic disc as an inside elliptical annulus. The flow density of the elliptical annulus area extending from the inside annulus to 0.75&#x02005;mm outward was then separately calculated in six regions (nasal, inferior-nasal, inferior-tempo, superior-tempo, superior-nasal and tempo) based on the Garway-Heath Map (<xref ref-type="fig" rid="BMJOPEN2016013571F1">figure 1</xref>B) on the radial peripapillary capillary (RPC) layer. The software also provided the whole en face flow density, peripapillary and inside disc flow density.</p></sec></sec><sec id="s2c"><title>Statistical analysis</title><p>Statistical analysis was performed using an SPSS software package (SPSS for Mac, V.22, IBM/SPSS, Chicago, Illinois, USA). The mean&#x000b1;SD of all the main parameters were analysed. One-way analysis of variance (ANOVA) was used to compare the differences of the macular, choriocapillaris and RPC flow densities among the three groups, and in post hoc procedures the Dunnett T3 test was used for multiple comparisons between groups: PM with EM group, PM with HM group, and EM with HM group. The &#x003c7;<sup>2</sup> test was applied to analyse the frequency data of gender. Multiple linear regression analysis was performed to analyse the effect of other independent variables on retinal, choriocapillary density of macular and RPC flow densities, respectively. A value of p&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Demographics</title><p>A total of 45 eyes (15 men and 30 women) were included in the EM group. The mean age was 38.3&#x000b1;13.1&#x02005;years, mean IOP was 14.8&#x000b1;2.6&#x02005;mm&#x02005;Hg, mean systolic blood pressure (SBP) was 114&#x000b1;13&#x02005;mm&#x02005;Hg, and mean diastolic blood pressure (DBP) was 75&#x000b1;8&#x02005;mm&#x02005;Hg. A total of 41 eyes (11 men and 30 women) were included in the HM group. The mean age was 33.3&#x000b1;15.0&#x02005;years, mean IOP was 15.3&#x000b1;2.6&#x02005;mm&#x02005;Hg, mean SBP was 117&#x000b1;13&#x02005;mm&#x02005;Hg and mean DBP was 78&#x000b1;9&#x02005;mm&#x02005;Hg. A total of 45 eyes (16 men and 29 women) were included in the PM group. The mean age was 38.0&#x000b1;11.7&#x02005;years, mean IOP was 15.3&#x000b1;2.8&#x02005;mm&#x02005;Hg, mean SBP was 114&#x000b1;10&#x02005;mm&#x02005;Hg and mean DBP was 77&#x000b1;7&#x02005;mm&#x02005;Hg. No significant differences were found in gender, age, IOP, DBP and SBP among the three groups (<xref ref-type="table" rid="BMJOPEN2016013571TB1">table 1</xref>).</p><table-wrap id="BMJOPEN2016013571TB1" orientation="portrait" position="float"><label>Table&#x000a0;1</label><caption><p>Demographic and ocular characteristics of the three groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">EM (N=45)</th><th align="left" rowspan="1" colspan="1">HM (N=41)</th><th align="left" rowspan="1" colspan="1">PM (N=45)</th><th align="left" rowspan="1" colspan="1">p Value*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Gender (male:female)</td><td rowspan="1" colspan="1">15:30</td><td rowspan="1" colspan="1">11:31</td><td rowspan="1" colspan="1">16:29</td><td rowspan="1" colspan="1">0.670&#x02020;</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">38.3&#x000b1;13.1</td><td rowspan="1" colspan="1">33.3&#x000b1;15.0</td><td rowspan="1" colspan="1">38.0&#x000b1;11.7</td><td rowspan="1" colspan="1">0.161</td></tr><tr><td rowspan="1" colspan="1">BCVA</td><td rowspan="1" colspan="1">1.0&#x000b1;0.2</td><td rowspan="1" colspan="1">0.9&#x000b1;0.2</td><td rowspan="1" colspan="1">0.6&#x000b1;0.3</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">IOP (mm&#x02005;Hg)</td><td rowspan="1" colspan="1">14.8&#x000b1;2.6</td><td rowspan="1" colspan="1">15.3&#x000b1;2.6</td><td rowspan="1" colspan="1">15.3&#x000b1;2.8</td><td rowspan="1" colspan="1">0.624</td></tr><tr><td rowspan="1" colspan="1">MSE (dioptres)</td><td rowspan="1" colspan="1">0.07&#x000b1;0.35</td><td rowspan="1" colspan="1">&#x02013;6.90&#x000b1;1.23</td><td rowspan="1" colspan="1">&#x02212;15.22&#x000b1;3.79</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">AL (mm)</td><td rowspan="1" colspan="1">23.19&#x000b1;0.58</td><td rowspan="1" colspan="1">25.93&#x000b1;0.58</td><td rowspan="1" colspan="1">29.55&#x000b1;1.73</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">SBP (mm&#x02005;Hg)</td><td rowspan="1" colspan="1">114&#x000b1;13</td><td rowspan="1" colspan="1">117&#x000b1;13</td><td rowspan="1" colspan="1">114&#x000b1;10</td><td rowspan="1" colspan="1">0.504</td></tr><tr><td rowspan="1" colspan="1">DBP (mm&#x02005;Hg)</td><td rowspan="1" colspan="1">75&#x000b1;8</td><td rowspan="1" colspan="1">78&#x000b1;9</td><td rowspan="1" colspan="1">77&#x000b1;7</td><td rowspan="1" colspan="1">0.221</td></tr></tbody></table><table-wrap-foot><fn><p>Significant p values are in bold.</p></fn><fn><p>*All calculated by one-way ANOVA, except</p></fn><fn><p>&#x02020;&#x003c7;<sup>2</sup> test was applied to analyse the frequency data of gender.</p></fn><fn><p>ANOVA, analysis of variance; AL, axial length; BCVA, best-corrected visual acuity; DBP, diastolic blood pressure; EM, emmetropia; HM, high myopia; IOP, intraocular pressure; MSE, mean spherical equivalent; PM, pathological myopia; SBP, systolic blood pressure.</p></fn></table-wrap-foot></table-wrap><p>However, there were significant differences in BCVA, MSE and AL among the three groups (<xref ref-type="table" rid="BMJOPEN2016013571TB1">table 1</xref>), and multiple comparisons revealed significant differences between the groups. The mean BCVA was 1.0&#x000b1;0.2 (range 0.8 to 1.5), 0.9&#x000b1;0.2 (range 0.3 to 1.5) and 0.6&#x000b1;0.3 (range 0.15 to 1.0) in the EM, HM and PM groups, respectively (p&#x0003c;0.001); the mean MSE was 0.07&#x000b1;0.35D (range &#x02212;0.50 to 0.50D), &#x02212;6.90&#x000b1;1.23D (range &#x02212;6.00 to &#x02212;11.00D), and &#x02212;15.22&#x000b1;3.79D (range &#x02212;8.25 to &#x02212;23.00D) in the EM, HM and PM groups, respectively (p&#x0003c;0.001); and the mean AL was 23.19&#x000b1;0.58&#x02005;mm (range 22.23 to 24.32&#x02005;mm), 25.93&#x000b1;0.58&#x02005;mm (range 24.76 to 28.19&#x02005;mm), and 29.55&#x000b1;1.73&#x02005;mm (range 27.22 to 33.77&#x02005;mm) in the EM, HM and PM groups, respectively (p&#x0003c;0.001; <xref ref-type="table" rid="BMJOPEN2016013571TB1">table 1</xref>).</p></sec><sec id="s3b"><title>Macular flow density</title><p>Both in the superficial and deep retinal layers significant differences among the three groups were found in all regions, except in the fovea. In the choriocapillaris layer, significant differences were found among the three groups (<xref ref-type="table" rid="BMJOPEN2016013571TB2">table 2</xref>). The PM group had decreased macular flow density: the superficial whole en face flow densities were 53.93&#x000b1;1.72%, 51.93&#x000b1;3.38% and 48.00&#x000b1;4.10% in the EM, HM and PM groups, respectively (p&#x0003c;0.001); the deep whole en face flow densities were 58.25&#x000b1;1.58%, 57.76&#x000b1;2.74% and 54.59&#x000b1;4.18% in the EM, HM and PM groups, respectively (p&#x0003c;0.001); and the choriocapillaris flow densities were 62.34&#x000b1;1.05%, 61.60&#x000b1;1.65% and 61.16&#x000b1;2.61% in the EM, HM and PM groups, respectively (p=0.013; <xref ref-type="table" rid="BMJOPEN2016013571TB2">table 2</xref>).</p><table-wrap id="BMJOPEN2016013571TB2" orientation="portrait" position="float"><label>Table&#x000a0;2</label><caption><p>Macular flow density of the three groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">EM (N=45)</th><th align="left" rowspan="1" colspan="1">HM (N=41)</th><th align="left" rowspan="1" colspan="1">PM (N=45)</th><th align="left" rowspan="1" colspan="1">p Value*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Superficial whole en face flow density (%)</td><td rowspan="1" colspan="1">53.93&#x000b1;1.72</td><td rowspan="1" colspan="1">51.93&#x000b1;3.38</td><td rowspan="1" colspan="1">48.00&#x000b1;4.10</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial fovea flow density (%)</td><td rowspan="1" colspan="1">29.07&#x000b1;4.14</td><td rowspan="1" colspan="1">28.94&#x000b1;6.15</td><td rowspan="1" colspan="1">30.59&#x000b1;4.55</td><td rowspan="1" colspan="1">0.228</td></tr><tr><td rowspan="1" colspan="1">Superficial parafovea flow density (%)</td><td rowspan="1" colspan="1">55.68&#x000b1;1.89</td><td rowspan="1" colspan="1">54.93&#x000b1;3.43</td><td rowspan="1" colspan="1">50.20&#x000b1;4.44</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial temporal flow density (%)</td><td rowspan="1" colspan="1">54.46&#x000b1;2.14</td><td rowspan="1" colspan="1">54.33&#x000b1;3.38</td><td rowspan="1" colspan="1">50.63&#x000b1;4.35</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial superior flow density (%)</td><td rowspan="1" colspan="1">56.69&#x000b1;2.21</td><td rowspan="1" colspan="1">55.96&#x000b1;3.83</td><td rowspan="1" colspan="1">50.66&#x000b1;5.69</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial nasal flow density (%)</td><td rowspan="1" colspan="1">54.82&#x000b1;1.91</td><td rowspan="1" colspan="1">54.29&#x000b1;3.28</td><td rowspan="1" colspan="1">49.45&#x000b1;4.70</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial inferior flow density (%)</td><td rowspan="1" colspan="1">56.74&#x000b1;2.43</td><td rowspan="1" colspan="1">55.18&#x000b1;4.73</td><td rowspan="1" colspan="1">50.19&#x000b1;5.23</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep whole en face flow density (%)</td><td rowspan="1" colspan="1">58.25&#x000b1;1.58</td><td rowspan="1" colspan="1">57.76&#x000b1;2.74</td><td rowspan="1" colspan="1">54.59&#x000b1;4.18</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep fovea flow density (%)</td><td rowspan="1" colspan="1">25.64&#x000b1;4.86</td><td rowspan="1" colspan="1">27.01&#x000b1;7.57</td><td rowspan="1" colspan="1">28.86&#x000b1;6.33</td><td rowspan="1" colspan="1">0.056</td></tr><tr><td rowspan="1" colspan="1">Deep parafovea flow density (%)</td><td rowspan="1" colspan="1">61.13&#x000b1;1.95</td><td rowspan="1" colspan="1">62.21&#x000b1;2.77</td><td rowspan="1" colspan="1">58.95&#x000b1;4.66</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep temporal flow density (%)</td><td rowspan="1" colspan="1">59.55&#x000b1;2.50</td><td rowspan="1" colspan="1">61.05&#x000b1;2.96</td><td rowspan="1" colspan="1">58.55&#x000b1;5.13</td><td rowspan="1" colspan="1"><bold>0.009</bold></td></tr><tr><td rowspan="1" colspan="1">Deep superior flow density (%)</td><td rowspan="1" colspan="1">62.32&#x000b1;2.26</td><td rowspan="1" colspan="1">63.07&#x000b1;2.85</td><td rowspan="1" colspan="1">58.45&#x000b1;5.91</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep nasal flow density (%)</td><td rowspan="1" colspan="1">60.24&#x000b1;2.23</td><td rowspan="1" colspan="1">61.49&#x000b1;3.65</td><td rowspan="1" colspan="1">59.29&#x000b1;4.79</td><td rowspan="1" colspan="1"><bold>0.025</bold></td></tr><tr><td rowspan="1" colspan="1">Deep inferior flow density (%)</td><td rowspan="1" colspan="1">62.40&#x000b1;2.35</td><td rowspan="1" colspan="1">63.33&#x000b1;3.49</td><td rowspan="1" colspan="1">59.50&#x000b1;6.34</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Choriocapillary flow density (%)</td><td rowspan="1" colspan="1">62.34&#x000b1;1.05</td><td rowspan="1" colspan="1">61.60&#x000b1;1.65</td><td rowspan="1" colspan="1">61.16&#x000b1;2.61</td><td rowspan="1" colspan="1"><bold>0.013</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Significant p values are in bold.</p></fn><fn><p>*All calculated by one-way ANOVA.</p></fn><fn><p>ANOVA, analysis of variance; EM, emmetropia; HM, high myopia; PM, pathological myopia.</p></fn></table-wrap-foot></table-wrap><p>In the superficial retinal layer, multiple comparisons revealed significant differences between the PM and EM groups, and also between the PM and HM groups, in all regions, while between the HM and EM groups there was a significant difference in whole en face flow density, but not in the parafovea, temporal, superior, nasal and inferior region (<xref ref-type="table" rid="BMJOPEN2016013571TB3">table 3</xref>).</p><table-wrap id="BMJOPEN2016013571TB3" orientation="portrait" position="float"><label>Table&#x000a0;3</label><caption><p>Multiple comparisons of macular flow density between the three groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" colspan="3" rowspan="1">p Value*<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">EM vs HM</th><th align="left" rowspan="1" colspan="1">EM vs PM</th><th align="left" rowspan="1" colspan="1">HM vs PM</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Superficial whole en face flow density</td><td rowspan="1" colspan="1"><bold>0.004</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial parafovea flow density</td><td rowspan="1" colspan="1">0.527</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial temporal flow density</td><td rowspan="1" colspan="1">0.996</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial superior flow density</td><td rowspan="1" colspan="1">0.640</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial nasal flow density</td><td rowspan="1" colspan="1">0.750</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Superficial inferior flow density</td><td rowspan="1" colspan="1">0.172</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep whole en face flow density</td><td rowspan="1" colspan="1">0.677</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep parafovea flow density</td><td rowspan="1" colspan="1">0.115</td><td rowspan="1" colspan="1"><bold>0.016</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep temporal flow density</td><td rowspan="1" colspan="1">0.194</td><td rowspan="1" colspan="1">0.618</td><td rowspan="1" colspan="1"><bold>0.007</bold></td></tr><tr><td rowspan="1" colspan="1">Deep superior flow density</td><td rowspan="1" colspan="1">0.461</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Deep nasal flow density</td><td rowspan="1" colspan="1">0.366</td><td rowspan="1" colspan="1">0.675</td><td rowspan="1" colspan="1"><bold>0.021</bold></td></tr><tr><td rowspan="1" colspan="1">Deep inferior flow density</td><td rowspan="1" colspan="1">0.397</td><td rowspan="1" colspan="1"><bold>0.017</bold></td><td rowspan="1" colspan="1"><bold>0.002</bold></td></tr><tr><td rowspan="1" colspan="1">Choriocapillary flow density</td><td rowspan="1" colspan="1"><bold>0.047</bold></td><td rowspan="1" colspan="1"><bold>0.020</bold></td><td rowspan="1" colspan="1">0.731</td></tr></tbody></table><table-wrap-foot><fn><p>Significant p values are in bold.</p></fn><fn><p>*All calculated by Dunnett T3 test.</p></fn><fn><p>EM, emmetropia; HM, high myopia; PM, pathological myopia.</p></fn></table-wrap-foot></table-wrap><p>In the deep retinal layer, between the PM and EM groups, multiple comparisons revealed significant differences in the whole en face, parafovea, superior and inferior region, but not in the temporal and nasal region; between the PM and HM groups, significant differences were found in all regions; between the HM and EM groups, no significant differences were found in all regions (<xref ref-type="table" rid="BMJOPEN2016013571TB3">table 3</xref>).</p><p>In the choriocapillaris layer, multiple comparisons revealed significant differences between the PM and EM groups, HM and EM groups, but not between the PM and HM groups (<xref ref-type="table" rid="BMJOPEN2016013571TB3">table 3</xref>).</p></sec><sec id="s3c"><title>RPC flow density</title><p>Significant differences among the three groups were found in all RPC regions, except inside the disc (<xref ref-type="table" rid="BMJOPEN2016013571TB4">table 4</xref>). The PM group had decreased RPC flow density: the optic disc's whole en face flow densities were 57.96&#x000b1;1.95%, 55.38&#x000b1;2.69% and 48.16&#x000b1;4.16% in the EM, HM and PM groups, respectively (p&#x0003c;0.001; <xref ref-type="table" rid="BMJOPEN2016013571TB4">table 4</xref>).</p><table-wrap id="BMJOPEN2016013571TB4" orientation="portrait" position="float"><label>Table&#x000a0;4</label><caption><p>RPC flow density of three groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="&#x000b1;" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">EM (N=45)</th><th align="left" rowspan="1" colspan="1">HM (N=41)</th><th align="left" rowspan="1" colspan="1">PM (N=45)</th><th align="left" rowspan="1" colspan="1">p Value*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Optic disc whole en face flow density (%)</td><td rowspan="1" colspan="1">57.96&#x000b1;1.95</td><td rowspan="1" colspan="1">55.38&#x000b1;2.69</td><td rowspan="1" colspan="1">48.16&#x000b1;4.16</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc inside disc flow density</td><td rowspan="1" colspan="1">43.87&#x000b1;7.28</td><td rowspan="1" colspan="1">45.15&#x000b1;9.94</td><td rowspan="1" colspan="1">45.38&#x000b1;8.98</td><td rowspan="1" colspan="1">0.699</td></tr><tr><td rowspan="1" colspan="1">Optic disc peripapillary flow density (%)</td><td rowspan="1" colspan="1">65.42&#x000b1;2.30</td><td rowspan="1" colspan="1">62.71&#x000b1;3.64</td><td rowspan="1" colspan="1">52.70&#x000b1;6.00</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc nasal flow density (%)</td><td rowspan="1" colspan="1">62.54&#x000b1;2.85</td><td rowspan="1" colspan="1">58.91&#x000b1;4.02</td><td rowspan="1" colspan="1">48.93&#x000b1;7.84</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc inferior nasal flow density (%)</td><td rowspan="1" colspan="1">65.68&#x000b1;3.92</td><td rowspan="1" colspan="1">62.02&#x000b1;6.63</td><td rowspan="1" colspan="1">52.22&#x000b1;8.71</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc inferior tempo flow density (%)</td><td rowspan="1" colspan="1">68.41&#x000b1;3.05</td><td rowspan="1" colspan="1">66.67&#x000b1;7.49</td><td rowspan="1" colspan="1">57.45&#x000b1;9.45</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc superior tempo flow density (%)</td><td rowspan="1" colspan="1">67.52&#x000b1;3.76</td><td rowspan="1" colspan="1">67.30&#x000b1;4.21</td><td rowspan="1" colspan="1">53.91&#x000b1;9.74</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc superior nasal flow density (%)</td><td rowspan="1" colspan="1">63.72&#x000b1;3.57</td><td rowspan="1" colspan="1">62.40&#x000b1;4.12</td><td rowspan="1" colspan="1">49.71&#x000b1;10.46</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc tempo flow density (%)</td><td rowspan="1" colspan="1">67.24&#x000b1;3.02</td><td rowspan="1" colspan="1">63.79&#x000b1;8.27</td><td rowspan="1" colspan="1">56.73&#x000b1;9.56</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Significant p values are in bold.</p></fn><fn><p>*All calculated by the one-way ANOVA.</p></fn><fn><p>ANOVA, analysis of variance; EM, emmetropia; HM, high myopia; PM, pathological myopia; RPC, radial peripapillary capillary.</p></fn></table-wrap-foot></table-wrap><p>Further multiple comparisons revealed significant differences between the PM and EM groups in all regions, and also between the PM and HM groups in all regions. Between the HM and EM groups, significant differences were found in the whole en face, peripapillary, nasal, inferior nasal and tempo region, but not in the inferior tempo, superior tempo and superior nasal region (<xref ref-type="table" rid="BMJOPEN2016013571TB5">table 5</xref>).</p><table-wrap id="BMJOPEN2016013571TB5" orientation="portrait" position="float"><label>Table&#x000a0;5</label><caption><p>Multiple comparisons of RPC flow density between the three groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" colspan="3" rowspan="1">p Value*<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">EM vs HM</th><th align="left" rowspan="1" colspan="1">EM vs PM</th><th align="left" rowspan="1" colspan="1">HM vs PM</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Optic disc whole en face flow density</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc peripapillary flow density</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc nasal flow density</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc inferior nasal flow density</td><td rowspan="1" colspan="1"><bold>0.009</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc inferior tempo flow density</td><td rowspan="1" colspan="1">0.426</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc superior tempo flow density</td><td rowspan="1" colspan="1">0.992</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc superior nasal flow density</td><td rowspan="1" colspan="1">0.312</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Optic disc tempo flow density</td><td rowspan="1" colspan="1"><bold>0.044</bold></td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1"><bold>0.004</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Significant p values are in bold.</p></fn><fn><p>*All calculated by Dunnett T3 test.</p></fn><fn><p>EM, emmetropia; HM, high myopia; PM, pathological myopia; RPC, radial peripapillary capillary.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d"><title>Correlation between AL and BCVA with macular flow density</title><p>By multiple linear regression analysis, both in the superficial and deep retinal layers AL was revealed to be significantly negatively correlated with whole en face flow density (superficial: &#x003b2;=&#x02212;0.542, p&#x0003c;0.001; deep: &#x003b2;=&#x02212;0.282, p=0.002). No significant correlation was found between AL and choriocapillary flow density. Both in the superficial and deep retinal layers BCVA was shown to be positively correlated with whole en face flow density (superficial: &#x003b2;=0.194, p=0.021; deep: &#x003b2;=0.373, p&#x0003c;0.001). BCVA was also shown to be positively correlated with choriocapillary flow density (&#x003b2;=0.291, p=0.001).</p></sec><sec id="s3e"><title>Correlation between AL and BCVA with the RPC flow density</title><p>By multiple linear regression analysis, AL was revealed to be negatively correlated with RPC whole en face flow density (&#x003b2;=&#x02212;0. 522, p&#x0003c;0.001), while no correlation was found between BCVA and RPC whole en face flow density.</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In this study, macular and peripapillary flow densities in pathologically myopic eyes were quantitatively measured by OCT angiography with SSADA.</p><p>Various techniques have been used to study ocular blood flow in HM and PM. Avetisov <italic>et al</italic><xref rid="R8" ref-type="bibr">8</xref> reported fluorescein transit time was delayed in pathologically myopic eyes. Akyol <italic>et al</italic><xref rid="R9" ref-type="bibr">9</xref> reported reduced choroidal and retinal blood flow in PM by using CDI. Shimada <italic>et al</italic><xref rid="R10" ref-type="bibr">10</xref> found decreased retinal blood flow and vessel diameter in HM by using laser Doppler velocimetry. Benavente-P&#x000e9;rez <italic>et al</italic><xref rid="R11" ref-type="bibr">11</xref> reported reduced retinal artery blood flow in high myopic eyes by using CDI. Spina <italic>et al</italic><xref rid="R17" ref-type="bibr">17</xref> reported reduced diameters of the main retinal vessels by using a dynamic vessel analyser in HM and PM. These studies revealed reduced choroidal and retinal blood flow in HM and PM. But these techniques were limited to measuring ocular blood flow in large vessels. OCT angiography was proven to be able to document in vivo choroidal and retinal vasculature including microvasculature in a non-invasive and quantitative way, and enabled high-resolution assessment of early and subtle changes in macular and papillary vasculature. Good repeatability and reproducibility of SSADA OCT angiography were reported in previous studies.<xref rid="R15" ref-type="bibr">15</xref>
<xref rid="R16" ref-type="bibr">16</xref>
<xref rid="R18" ref-type="bibr">18</xref>
<xref rid="R19" ref-type="bibr">19</xref> There are few quantitative studies of vascular density by OCT angiography in PM. Wang <italic>et al</italic><xref rid="R20" ref-type="bibr">20</xref> studied macular and peripapillary perfusion by OCT angiography only in high myopic eyes, while this study focused on pathologically myopic eyes.</p><p>In agreement with previous studies, in this study the PM and HM groups had decreased choriocapillary flow densities compared with the EM group; however, no significant difference was found between the PM and HM groups. One study showed that in pathologically myopic eyes severe choriocapillaris atrophy was present and the normal anatomic levels were displaced,<xref rid="R7" ref-type="bibr">7</xref> but the choriocapillaris layer was still autosegmented by software from RPE with an RPE offset of 31&#x02013;59&#x02005;&#x000b5;m. Thus the flow density actually measured might include the medium-size choroidal vessels or even the deeper large-size choroidal vessels instead of choriocapillaris only; that might explain why there is no significant difference in choriocapillary flow density between the PM and HM groups in this study.</p><p>Both in the superficial and deep retina, decreased macular flow density was found in the PM group compared with the HM and EM groups, except in the foveal region and the deep temporal and deep nasal region. Between the HM and EM groups, except for superficial whole en face flow density, no differences were found both in the superficial and deep retina, in accordance with a previous study.<xref rid="R20" ref-type="bibr">20</xref> These results indicate that decreased macular flow density was only found in pathologically myopic eyes, but not in HM eyes. Maybe the foveal region was mainly an avascular zone, so it&#x000a0;is less sensitive to detecting some differences among groups. It is hard to explain why no differences were found in the deep temporal and deep nasal regions; perhaps a larger sample was needed.</p><p>Radial peripapillary capillaries (RPCs) comprise a unique network of capillary beds within a retinal nerve fibre layer (RNFL) and play a critical role in providing nutritional requirements of retinal ganglion cell axons. Previous studies have reported that RPC capillary density was significantly greater in the arcuate fibre region (inferior temporal and superior temporal regions). The unique metabolic demands of neuronal subcompartments may influence the morphometric features of regional capillary networks, and differences in capillary density may have important correlations with neuronal function in the human retina.<xref rid="R21" ref-type="bibr">21</xref> Wang <italic>et al</italic><xref rid="R20" ref-type="bibr">20</xref> reported decreased peripapillary perfusion in high myopic eyes by OCT angiography. In this study, RPC flow density was significantly decreased in the PM group compared with the HM and EM groups, except the inside disc region. Perhaps the complex composition of large vessels inside the disc made it less sensitive to detecting the differences among groups. Our results also revealed RPC whole en face flow density was significantly decreased in the HM group compared with the EM group in the peripapillary, nasal, inferior nasal and tempo regions, but not in the inferior temporal, superior temporal and superior nasal regions. This result indicated that the RPC flow density in high myopic eyes might be preserved in the arcuate fibre region to satisfy the metabolic demands of the RNFL. As previously mentioned, no significant decreases were found in macular flow densities of high myopic eyes; such relative preservation of retinal vascular flow density might ensure the normal visual function of high myopic eyes.</p><p>Spina <italic>et al</italic><xref rid="R17" ref-type="bibr">17</xref> reported reduced dimensions of the main retinal vessels appeared inversely related to AL, and Yang <italic>et al</italic><xref rid="R22" ref-type="bibr">22</xref> reported ocular blood flow was negatively related to AL. In accordance with these studies, this study found that both macular and RPC flow densities were negatively related to AL by multiple linear regression analysis. The mechanism of decreased retinal and choroidal perfusion in pathological myopic eyes is still unclear. Studies demonstrated that retinal and choroidal thickness decreased in HM and PM.<xref rid="R23" ref-type="bibr">23&#x02013;25</xref> Man <italic>et al</italic><xref rid="R26" ref-type="bibr">26</xref> highlighted how longer eyes had decreased retinal function and oxygen consumption. It was commonly thought that in pathologically myopic eyes excessive elongation of the eyeball could cause thinning of the retina and choroid, and the thinning of these tissues might decrease the oxygen demand and consequently decrease the blood circulation. But whether decreased blood flow was only a consequence of chorioretinal atrophy or was involved in the development of PM is still unknown. Moreover, our results demonstrated that only macular flow density was positively related to BCVA. The results confirmed that the macular vasculature system was essential to visual function, suggesting that improvement of macular perfusion might increase the visual function of PM. However, the mechanisms of decreased ocular perfusion and how to preserve or improve perfusion of PM requires further study.</p><p>Image artefacts were not uncommon in OCT angiography, and must be taken into account for appropriate interpretation.<xref rid="R27" ref-type="bibr">27</xref> Although OCT angiography has proven to be an effective and non-invasive method for monitoring macular and peripapillary perfusion, in this study we noticed that the use of OCT angiography was limited in pathologically myopic eyes. First, we know that ocular movements, even subtle, can cause significant artefacts on OCT angiography; thus some pathologically myopic eyes with poor visual acuity and fixation could hardly obtain a good quality image. Second, when severe chorioretinal lesions, such as chorioretinal atrophy, foveoschisis or retinal detachment, were present and the normal anatomic levels were displaced, an error of automated segmentation by OCT angiography or projection artefacts might occur. Third, the OCT signal might be compromised by severe vitreous opacities, which are common in PM.</p><p>This study had some limitations: it is a single-centre cross-sectional study with a monoracial background, involving a limited number of cases; a further study with a larger sample size might tell us more about the ocular vasculature in PM. The links between vascular changes with visual functionality in pathologically myopic eyes are still unclear; thus, a follow-up study on the relationship between ocular circulation using OCT angiography with retinal function might be able to improve our understanding of the pathophysiology in PM.</p><p>In conclusion, this study aimed to investigate the vascular flow density in PM by using OCT angiography; the results demonstrated a reduced macular and peripapillary flow density in pathologically myopic eyes. No significant decrease of retinal flow density in the macular and arcuate fibre region was found in high myopic eyes compared with emmetropic eyes. In addition, the macular and peripapillary flow density was shown to be negatively related to AL and macular flow density was positively related to BCVA. It is worth noting that there are some limitations in the use of OCT angiography in PM. Improvement of macular perfusion might increase the visual function of PM, but mechanisms of the decreased ocular perfusion and how to preserve or improve perfusion in pathologically myopic eyes requires further study.</p></sec></body><back><fn-group><fn><p><bold>Contributors:</bold> WW and JM conceived of and designed the study. JM, AD and XW performed the study. JM and SC analysed the data. WW and JM wrote the manuscript.</p></fn><fn><p><bold>Funding:</bold> This work was supported by the Beijing Municipal Administration of Hospitals' Ascent Plan(code: DFL20150201); Science &#x00026; Technology Project of Beijing Municipal Science &#x00026; Technology Commission (code: Z151100001615052); National Natural Science Foundation of China (Nr.81570891); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307); National Natural Science Foundation of China (Nr. 81272981); Beijing Natural Science Foundation (Nr. 7151003); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau No. 2014-2-003.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn><p><bold>Patient consent:</bold> Obtained.</p></fn><fn><p><bold>Ethics approval:</bold> This study was approved by the Medical Ethics Committee of the Beijing Tongren Hospital.</p></fn><fn><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn><p><bold>Data sharing statement:</bold> No additional data are available.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cedrone</surname><given-names>C</given-names></name>, <name><surname>Nucci</surname><given-names>C</given-names></name>, <name><surname>Scuderi</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Prevalence of blindness and low vision in an Italian population: a comparison with other European studies</article-title>. <source>Eye (Lond)</source>
<year>2006</year>;<volume>20</volume>:<fpage>661</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.eye.6701934">doi:10.1038/sj.eye.6701934</ext-link><pub-id pub-id-type="pmid">15920565</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buch</surname><given-names>H</given-names></name>, <name><surname>Vinding</surname><given-names>T</given-names></name>, <name><surname>Nielsen</surname><given-names>NV</given-names></name></person-group>
<article-title>Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study</article-title>. <source>Ophthalmology</source>
<year>2001</year>;<volume>108</volume>:<fpage>
2347</fpage>&#x02013;<lpage>57</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0161-6420(01)00823-5">doi:10.1016/S0161-6420(01)00823-5</ext-link><pub-id pub-id-type="pmid">11733284</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study</article-title>. <source>Ophthalmology</source>
<year>2006</year>;<volume>113</volume>:<fpage>1134.e1</fpage>&#x02013;<lpage>11</lpage><comment>. e1111</comment>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2006.01.035">doi:10.1016/j.ophtha.2006.01.035</ext-link><pub-id pub-id-type="pmid">16647133</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>WM</given-names></name>, <name><surname>Cheng</surname><given-names>CY</given-names></name>, <name><surname>Liu</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study</article-title>. <source>Ophthalmology</source>
<year>2004</year>;<volume>111</volume>:<fpage>62</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2003.05.011">doi:10.1016/j.ophtha.2003.05.011</ext-link><pub-id pub-id-type="pmid">14711715</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>A</given-names></name>, <name><surname>Araie</surname><given-names>M</given-names></name>, <name><surname>Tomidokoro</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study</article-title>. <source>Ophthalmology</source>
<year>2006</year>;<volume>113</volume>:<fpage>1354</fpage>&#x02013;<lpage>62</lpage>. <comment>e1351</comment>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2006.04.022">doi:10.1016/j.ophtha.2006.04.022</ext-link><pub-id pub-id-type="pmid">16877074</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno-Matsui</surname><given-names>K</given-names></name>, <name><surname>Kawasaki</surname><given-names>R</given-names></name>, <name><surname>Jonas</surname><given-names>JB</given-names></name><etal/></person-group>
<article-title>International photographic classification and grading system for myopic maculopathy</article-title>. <source>Am J Ophthalmol</source>
<year>2015</year>;<volume>159</volume>:<fpage>877</fpage>&#x02013;<lpage>883.e7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajo.2015.01.022">doi:10.1016/j.ajo.2015.01.022</ext-link><pub-id pub-id-type="pmid">25634530</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>JB</given-names></name>, <name><surname>Xu</surname><given-names>L</given-names></name></person-group>
<article-title>Histological changes of high axial myopia</article-title>. <source>Eye (Lond)</source>
<year>2014</year>;<volume>28</volume>:<fpage>113</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/eye.2013.223">doi:10.1038/eye.2013.223</ext-link><pub-id pub-id-type="pmid">24113300</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avetisov</surname><given-names>ES</given-names></name>, <name><surname>Savitzkaya</surname><given-names>NF</given-names></name></person-group>
<article-title>Some features in ocular microcirculation in myopia</article-title>. <source>Ann Ophthalmol</source>
<year>1977</year>;<volume>9</volume>:<fpage>1261</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">921147</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akyol</surname><given-names>N</given-names></name>, <name><surname>K&#x000fc;kner</surname><given-names>AS</given-names></name>, <name><surname>Ozdemir</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Choroidal and retinal blood flow changes in degenerative myopia</article-title>. <source>Can J Ophthalmol</source>
<year>1996</year>;<volume>31</volume>:<fpage>113</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="pmid">8743218</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>N</given-names></name>, <name><surname>Ohno-Matsui</surname><given-names>K</given-names></name>, <name><surname>Harino</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Reduction of retinal blood flow in high myopia</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<year>2004</year>;<volume>242</volume>:<fpage>284</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">14722781</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benavente-P&#x000e9;rez</surname><given-names>A</given-names></name>, <name><surname>Hosking</surname><given-names>SL</given-names></name>, <name><surname>Logan</surname><given-names>NS</given-names></name><etal/></person-group>
<article-title>Ocular blood flow measurements in healthy human myopic eyes</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<year>2010</year>;<volume>248</volume>:<fpage>1587</fpage>&#x02013;<lpage>94</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00417-010-1407-9">doi:10.1007/s00417-010-1407-9</ext-link><pub-id pub-id-type="pmid">20502909</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaide</surname><given-names>RF</given-names></name>, <name><surname>Klancnik</surname><given-names>JM</given-names></name>, <name><surname>Cooney</surname><given-names>MJ</given-names></name></person-group>
<article-title>Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography</article-title>. <source>JAMA Ophthalmol</source>
<year>2015</year>;<volume>133</volume>:<fpage>45</fpage>&#x02013;<lpage>50</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jamaophthalmol.2014.3616">doi:10.1001/jamaophthalmol.2014.3616</ext-link><pub-id pub-id-type="pmid">25317632</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaranta</surname><given-names>M</given-names></name>, <name><surname>Arnold</surname><given-names>J</given-names></name>, <name><surname>Coscas</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Indocyanine green angiographic features of pathologic myopia</article-title>. <source>Am J Ophthalmol</source>
<year>1996</year>;<volume>122</volume>:<fpage>663</fpage>&#x02013;<lpage>71</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0002-9394(14)70484-2">doi:10.1016/S0002-9394(14)70484-2</ext-link><pub-id pub-id-type="pmid">8909205</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y</given-names></name>, <name><surname>Tan</surname><given-names>O</given-names></name>, <name><surname>Tokayer</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Split-spectrum amplitude-decorrelation angiography with optical coherence tomography</article-title>. <source>Biomed Opt Express</source>
<year>2012</year>;<volume>20</volume>:<fpage>4710</fpage>&#x02013;<lpage>25</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1364/OE.20.004710">doi:10.1364/OE.20.004710</ext-link></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y</given-names></name>, <name><surname>Wei</surname><given-names>E</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Optical coherence tomography angiography of optic disc perfusion in glaucoma</article-title>. <source>Ophthalmology</source>
<year>2014</year>;<volume>121</volume>:<fpage>1322</fpage>&#x02013;<lpage>32</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2014.01.021">doi:10.1016/j.ophtha.2014.01.021</ext-link><pub-id pub-id-type="pmid">24629312</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Jiang</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<year>2015</year>;<volume>56</volume>:<fpage>3212</fpage>&#x02013;<lpage>17</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.14-16270">doi:10.1167/iovs.14-16270</ext-link><pub-id pub-id-type="pmid">26024105</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spina</surname><given-names>CL</given-names></name>, <name><surname>Corvi</surname><given-names>F</given-names></name>, <name><surname>Bandello</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Static characteristics and dynamic functionality of retinal vessels in longer eyes with or without pathologic myopia</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<year>2016</year>;<volume>254</volume>:<fpage>827</fpage>&#x02013;<lpage>34</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00417-015-3122-z">doi:10.1007/s00417-015-3122-z</ext-link><pub-id pub-id-type="pmid">26245340</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Jiang</surname><given-names>C</given-names></name>, <name><surname>Ko</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<year>2015</year>;<volume>253</volume>:<fpage>1557</fpage>&#x02013;<lpage>64</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00417-015-3095-y">doi:10.1007/s00417-015-3095-y</ext-link><pub-id pub-id-type="pmid">26255817</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>E</given-names></name>, <name><surname>Jia</surname><given-names>Y</given-names></name>, <name><surname>Tan</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Parafoveal retinal vascular response to pattern visual stimulation assessed with OCT angiography</article-title>. <source>PLoS One</source>
<year>2013</year>;<volume>8</volume>:<fpage>e81343</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0081343">doi:10.1371/journal.pone.0081343</ext-link><pub-id pub-id-type="pmid">24312549</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Kong</surname><given-names>X</given-names></name>, <name><surname>Jiang</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Is the peripapillary retinal perfusion related to myopia in healthy eyes? A prospective comparative study.</article-title>
<source>BMJ Open</source>
<year>2016</year>;<volume>6</volume>:<fpage>e010791</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2015-010791">doi:10.1136/bmjopen-2015-010791</ext-link></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>PE</given-names></name>, <name><surname>Yu</surname><given-names>PK</given-names></name>, <name><surname>Balaratnasingam</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Quantitative confocal imaging of the retinal microvasculature in the human retina</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<year>2012</year>;<volume>53</volume>:<fpage>5728</fpage>&#x02013;<lpage>36</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.12-10017">doi:10.1167/iovs.12-10017</ext-link><pub-id pub-id-type="pmid">22836777</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>YS</given-names></name>, <name><surname>Koh</surname><given-names>JW</given-names></name></person-group>
<article-title>Choroidal blood flow change in eyes with high myopia</article-title>. <source>Korean J Ophthalmol</source>
<year>2015</year>;<volume>29</volume>:<fpage>309</fpage>&#x02013;<lpage>14</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3341/kjo.2015.29.5.309">doi:10.3341/kjo.2015.29.5.309</ext-link><pub-id pub-id-type="pmid">26457036</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno-Matsui</surname><given-names>K</given-names></name>, <name><surname>Lai</surname><given-names>TY</given-names></name>, <name><surname>Lai</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>Updates of pathologic myopia</article-title>. <source>Prog Retin Eye Res</source>
<year>2016</year>;<volume>52</volume>:<fpage>156</fpage>&#x02013;<lpage>87</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.preteyeres.2015.12.001">doi:10.1016/j.preteyeres.2015.12.001</ext-link>.<pub-id pub-id-type="pmid">26769165</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Choroidal thickness and high myopia: a cross-sectional study and meta-analysis</article-title>. <source>BMC Opthalmol</source>
<year>2015</year>;<volume>15</volume>:<fpage>70</fpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12886-015-0059-2">doi:10.1186/s12886-015-0059-2</ext-link></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicinelli</surname><given-names>MV</given-names></name>, <name><surname>Pierro</surname><given-names>L</given-names></name>, <name><surname>Gagliardi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>2015. Optical coherence tomography and pathological myopia: an update of the literature</article-title>. <source>Int Ophthalmol</source>
<year>2015</year>;<volume>35</volume>:<fpage>897</fpage>&#x02013;<lpage>902</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10792-015-0118-y">doi:10.1007/s10792-015-0118-y</ext-link><pub-id pub-id-type="pmid">26265324</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>RE</given-names></name>, <name><surname>Lamoureux</surname><given-names>EL</given-names></name>, <name><surname>Taouk</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Axial length, retinal function, and oxygen consumption: a potential mechanism for a lower risk of diabetic retinopathy in longer eyes</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<year>2013</year>;<volume>54</volume>:<fpage>7691</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.13-12412">doi:10.1167/iovs.13-12412</ext-link><pub-id pub-id-type="pmid">24168995</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaide</surname><given-names>RF</given-names></name>, <name><surname>Fujimoto</surname><given-names>JG</given-names></name>, <name><surname>Waheed</surname><given-names>NK</given-names></name></person-group>
<article-title>Image artifacts in optical coherence tomography angiography</article-title>. <source>Retina</source>
<year>2015</year>;<volume>35</volume>:<fpage>2163</fpage>&#x02013;<lpage>80</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/"/></comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0000000000000765">http://dx.doi.org/10.1097/IAE.0000000000000765</ext-link><pub-id pub-id-type="pmid">26428607</pub-id></mixed-citation></ref></ref-list></back></article>